Amgen Inc.
KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
Last updated:
Abstract:
Provided herein are methods of treating cancer with KRAS G12C inhibitors and compositions of the same. These inhibitors are useful for treating a number of disorders, including pancreatic, colorectal, and lung cancers.
Status:
Application
Type:
Utility
Filling date:
5 Nov 2019
Issue date:
5 Mar 2020